hepatitis CHIVHCVchemsexPrEP
…t-acting antivirals (DAAs) on hepatitis C control, acute/recent hepatitis C virus (HCV) infections continue to be diagnosed in contemporary…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 162 of 2459multiple myeloma177LuABDB6177Lu]Lu-DOTA-ABDB6Lu-DOTA-ABDB6CD70CD70-targetedMM89Zr
…Background CD70, overexpressed in multiple myeloma (MM), is a promising target for theranostics. This study develo…
PDE5iRoyal Papworth HospitalriociguatCTEPHchronic thromboembolic PH (CTEPH)ERAPulmonary hypertensionBPAendothelin receptor antagonist
…triuretic peptide (−67% vs −21% vs −32%, p=0.004) compared with PDE5i monotherapy and riociguat monotherapy. These differences persis…
tenofovirHIVemtricitabineUniversity of California in San FranciscoHIV-1CAB/RPV LA
…ed by self-report, pharmacy dispensing records, plasma and hair tenofovir therapeutic drug monitoring (TDM). HIV diagnosis, resistance te…
sine sclerodermaCONQUERlcSScantiTOPOenteral/parenteral nutritionLimited cutaneous Systemic sclerosis
…f patients with early SSc, 5% and 11% of patients with lcSSc or sine scleroderma experienced disease progression at 12 and 24 months, respective…
lymphogranuloma venereumanogenital wartsgenital herpesnon-gonococcal non-chlamydial urethritismolluscum contagiosumgonorrhoeainfectious syphilisnon-gonococcal non-chlamydial vaginitisItalian STI Sentinel Surveillance Systemlatent syphilis+1 more
…d markedly across STIs: from 45.5% (5/11; 95% CI: 19.8–70.2) in lymphogranuloma venereum, 25.1% (136/542; 95% CI: 21.4–28.7), in latent syphilis, 22.3% …
smallpoxsmallpox-naïveMVA-BNMpoxsmallpox-vaccinatedHIV
…ars (IQR 53.6–61.1) ( table 1); 6.7% had a history of childhood smallpox vaccination. Fifty-three (52%) were people living with HIV, mos…
blebbistatinKD025Y-27632rh-TGFβSkin fibrosissystemic sclerosis (SSc)SSc
…blasts stimulated with rh- TGFβ (n=10) using the NMII inhibitor blebbistatin, the pan-ROCK inhibitor Y-27632, and the ROCK2-selective inhibi…
University of PittsburghcancerSScsystemic sclerosis (SSc)lupusSjogren’spulmonary fibrosis
…patients seen for an initial visit between 1980 and 2015 at the University of Pittsburgh. All SSc patients who entered our prospective SSc observational…
prostanoidsVVDssystemic sclerosis-associated interstitial lung disease (SSc-ILD)SSc-ILDendothelin-receptor antagonists
…ficant, independent impact on mortality.Conclusions Exposure to prostanoids is associated with lower risk of ILD progression in patients wi…
tocilizumabmycophenolate mofetilrituximababataceptABASSc-ILDTCZRTXcyclophosphamideazathioprine+4 more
…analyze long term outcome of patients with SSc-ILD treated with tocilizumab (TCZ), rituximab (RTX), and abatacept (ABA) which became availa…